Skip to Main Content

Paper Details

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment.
Brain Commun
11
2022
Author NameAffiliation
Bradley T HymanAlzheimer's Clinical & Translational Research Unit and Massachusetts Alzheimer's Disease Research Center, Harvard Medical School, Massachusetts General Hospital
Steven E ArnoldAlzheimer's Clinical & Translational Research Unit and Massachusetts Alzheimer's Disease Research Center, Harvard Medical School, Massachusetts General Hospital
  • 1 - 2

Datasets

Release 1.2